KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+0.52%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$955M
AUM Growth
+$955M
(+6.3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
1.88%
Top 10 Holdings %
Top 10 Hldgs %
87.58%
Holding
27
New
1
Increased
17
Reduced
3
Closed
–
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$31.9M |
| 2 |
Viridian Therapeutics
VRDN
|
$21M |
| 3 |
Celldex Therapeutics
CLDX
|
$18.1M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$14.2M |
| 5 |
Cogent Biosciences
COGT
|
$6.41M |
Top Sells
| 1 |
BNR
Burning Rock Biotech
BNR
|
$55.9M |
| 2 |
Liquidia Corp
LQDA
|
$16M |
| 3 |
Protagonist Therapeutics
PTGX
|
$11.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $218M | 16.83% | 2,014,408 +14,408 | +0.7% | +$1.56M |
|
|
2
Celldex Therapeutics
CLDX
$1.47B
| $125M | 9.67% | 3,388,967 +488,967 | +17% | +$18.1M |
|
3
Syndax Pharmaceuticals
SNDX
$1.41B
| $117M | 9.06% | 5,722,057 +62,057 | +1% | +$1.27M |
|
|
4
Dynavax Technologies
DVAX
$1.19B
| $79.5M | 6.14% | 7,082,562 +2,842,782 | +67% | +$31.9M |
|
|
5
Cogent Biosciences
COGT
$1.69B
| $78.1M | 6.02% | 9,260,385 +760,385 | +9% | +$6.41M |
|
6
Vaxcyte
PCVX
$4B
| $56.9M | 4.39% | 753,240 +8,240 | +1% | +$622K |
|
7
Vera Therapeutics
VERA
$1.38B
| $55.8M | 4.31% | 1,543,669 +16,882 | +1% | +$611K |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $54.5M | 4.21% | 8,826,710 +2,299,219 | +35% | +$14.2M |
|
|
9
Protagonist Therapeutics
PTGX
$3.67B
| $27.7M | 2.14% | 800,000 -344,242 | -30% | -$11.9M |
|
|
TSVT
10
DELISTED
2seventy bio
TSVT
| $22.9M | 1.77% | 5,953,825 | – | – |
|
|
11
Viridian Therapeutics
VRDN
$1.5B
| $22.8M | 1.76% | 1,750,000 +1,616,123 | +1,207% | +$21M |
|
12
Wave Life Sciences
WVE
$1.53B
| $19.8M | 1.53% | 3,975,521 +43,439 | +1% | +$217K |
|
13
Travere Therapeutics
TVTX
$1.56B
| $16.6M | 1.28% | 2,021,659 +21,659 | +1% | +$178K |
|
|
14
Liquidia Corp
LQDA
$2.38B
| $11M | 0.85% | 916,574 -1,331,750 | -59% | -$16M |
|
15
Ironwood Pharmaceuticals
IRWD
$214M
| $10.7M | 0.83% | 1,641,891 +16,891 | +1% | +$110K |
|
16
Tyra Biosciences
TYRA
$675M
| $9.06M | 0.7% | 566,715 +51,525 | +10% | +$824K |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $8.36M | 0.65% | 12,155,830 +132,873 | +1% | +$91.4K |
|
|
BNR
18
Burning Rock Biotech
BNR
$93.6M
| $6.28M | 0.48% | 974,668 -8,666,246 | -90% | -$55.9M |
|
19
Sutro Biopharma
STRO
$72.7M
| $5.93M | 0.46% | 2,023,683 +21,956 | +1% | +$64.3K |
|
|
SLRN
20
DELISTED
ACELYRIN
SLRN
| $3.67M | 0.28% | 831,310 +434,931 | +110% | +$1.92M |
|
21
Caribou Biosciences
CRBU
$174M
| $2.7M | 0.21% | 1,646,702 +578,175 | +54% | +$948K |
|
22
CG Oncology
CGON
$2.04B
| $1.7M | 0.13% | +53,911 | New | +$1.7M |
|
23
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – | 0 | – | – |
|
24
Corcept Therapeutics
CORT
$7.35B
| – | – | 0 | – | – |
|
25
Insmed
INSM
$28.8B
| – | – | 0 | – | – |
|